SMAD3 and hydrops fetalis: Based on the results described above, we determined that HF-MSCs inhibited pathological activation of JS1 cells and that activation of the TGF-β signaling pathway, as determined by Smad3 phosphorylation, was also suppressed in the HF-MSC group.